10031-30-8. Calcium dihydrogenphosphate hydrate. Calcium phosphate, monobasic, monohydrate. UNII-0N4E6L5449. Calcium phosphate monobasic monohydrate
Health hazard: 2 Flammability: 0 Physical hazards: 0 NFPA Rating Health hazard: 2 Fire: 0 Reactivity Hazard: 0 Potential Health Effects Inhalation May be harmful if inhaled. Causes respiratory tract irritation. Skin May be harmful if absorbed through skin. Causes skin irritation. Eyes Causes eye irritation.
CALCIUM DIHYDROGEN PHOSPHATE MONOHYDRATE, 7758-23-8, Inorganic Phosphates, Ca(H2PO4)2.H2O by Loba Chemie, India
Search results for Calcium dihydrogen phosphate at Sigma-Aldrich
General Information Acute toxicity: No adverse effects expected; however, large amounts may cause gastrointestinal disturbance, nausea, headache and vomiting. Skin corrosion/irritation: Causes skin irritation.
Dec 05, 2016· Visicol (sodium phosphate monobasic monohydrate, sodium phosphate dibasic anhydrous) contains forms of phosphorus and is used to treat constipation and to clean the bowel before surgery, x-rays, endoscopy, or other intestinal procedures. Sodium biphosphate and sodium phosphate enemas are also used for general care after surgery …
The encoded protein contains 11 conserved cysteine residues and is phosphorylated by protein kinase C exclusively on its serine residues. The protein may play a role in the regulation of renal and intestinal calcium and phosphate transport, cell metabolism, or cellular calcium/phosphate …
Calcium Phosphate Monobasic Anhydrous (CAS No) 7758-23-8 100 Eye Dam. 1, H318 Full text of H-phrases: see section 16 3.2. Mixture Not applicable SECTION 4: First aid measures 4.1. Description of first aid measures First-aid measures general : GENERAL. Check the vital functions. Unconscious: maintain adequate airway and respiration.
Aug 01, 2019· Sodium Phosphates Injection, USP, 3 mmol/mL (millimoles/mL), is a sterile, nonpyrogenic, concentrated solution containing a mixture of monobasic sodium phosphate and dibasic sodium phosphate in Water for Injection. The solution is administered after dilution by the intravenous route as an electrolyte replenisher.
/EXPERIMENTAL THERAPY:/ The bioavailability and clinical effects of potassium phosphate monobasic and potassium phosphate dibasic were tested in 16 parenterally fed low birth weight infants at standard (n=8) and high levels (n=8) of mineral intakes using a constant infusion of macronutrients and vitamin D in a crossover design of 2 four-day periods.